New Tracxn report highlights growing investor confidence in automated cell therapy production, with Cellares and Ori Biotech dominating funding and regulatory milestones
The landmark legislation has laid the foundation for a skilled, regulated and globally competitive Allied and Healthcare Professional workforce, reshaping healthcare education and delivery across India
Collaboration combines Lupin’s inhaler manufacturing capabilities with ERN’s strong commercial presence to expand access to respiratory care
SERB has a substantial European commercial presence and a successful track record in critical care and rare disease commercialization
Funding to accelerate development of integrated DNA platform supporting vaccines, gene therapies and advanced biologics
This is an exciting and meaningful milestone for GRIN Therapeutics
The summit will bring together 1,200+ delegates, 100+ international faculty from 25 countries
IgAN is a rare, progressive kidney disease driven by abnormal IgA immune complexes that deposit in the kidneys
The Clinical Trial Application (CTA) approval clears the way for the company to launch trial locations in France and Romania
Both companies say the collaboration is driven by a shared mission to improve patient outcomes by aligning every step of the diagnostic process
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
